Chicago Partners Investment Group LLC Connect Biopharma Holdings LTD Transaction History

Chicago Partners Investment Group LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	BUY	$0.56 - $3.25 $595 - $3,454	1,063 Added 5.43%	20,651 $17,000
Q1 2022 May 20, 2022	SELL	$2.46 - $5.92 $5,667 - $13,639	-2,304 Reduced 10.52%	19,588 $17,000
Q4 2021 Feb 15, 2022	BUY	$4.26 - $23.33 $93,259 - $510,740	21,892 New	21,892 $97,000

3.03M

Ticker CNTB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,015,800
Market Cap $55.6M
Description
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Chicago Partners Investment Group LLC with notifications on news.